|
The device history record was reviewed and indicated that the product was released accomplishing all quality standards.During the manufacturing process, a sampling of devices was visually inspected and physically tested with no issues recorded relating to the customer report.The product was manufactured between august 4th and 5th, 2022.The manufacturing site received one opened unit carton with 4 unsealed softpack packages with syringe assemblies included and 7 sealed softpack packages with syringe assemblies included.A total of 28 syringe assemblies were received for analysis.A complete investigation was performed.Visual inspection to the quality inspection standard was conducted on the samples and no issues were found relating to the reported condition.Control mechanisms are in place to prevent the occurrence and acceptance of the reported condition during molding, printing, assembly, and packaging processes, and to ensure components and finished product meet all quality inspection standards during the syringe assembly processes.Per procedure, complaint trends are evaluated during a monthly corrective and preventative action (capa) meeting to determine if a capa is warranted.At this time, there is not enough information and a capa will not be initiated.This complaint will be used for tracking and trending purposes.
|